Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/16/2011CN101204582B Multivalent hepatitis B fusion protein targeted adjuvant vaccine, preparation method and uses thereof
11/16/2011CN101203603B Agglutinin-like protein kinase stress-related polypeptides and methods of use in plants
11/16/2011CN101189343B Multiple rna polymerase iii promoter expression constructs
11/16/2011CN101128182B Heavy chain and domain antibodies
11/16/2011CN101121753B Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell
11/16/2011CN101103112B Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
11/16/2011CN101068826B Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/16/2011CN101062944B Vegetable disease-resistant protein and its coding gene and application
11/16/2011CN101012454B Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
11/15/2011US8058533 Maize variety hybrid 10183480
11/15/2011US8058523 Maize variety PHHTE
11/15/2011US8058522 Maize variety PHWNY
11/15/2011US8058521 Garden bean cultivar H37112
11/15/2011US8058519 Soybean variety XB20W09
11/15/2011US8058518 Soybean variety XB15Q09
11/15/2011US8058517 Delta-8 desaturase and its use in making polyunsaturated fatty acids
11/15/2011US8058516 Rice metallothionein promoters
11/15/2011US8058515 Plant cells and plants overexpressing vacuolar proton pyrophosphatases
11/15/2011US8058514 Agrobacterium-mediated method for producing transformed plant without selection step
11/15/2011US8058513 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
11/15/2011US8058512 Gene expression and production of TGF-β proteins including bioactive mullerian inhibiting substance from plants
11/15/2011US8058511 Expression vector for use as tool in transfer of exogenous genes into cells
11/15/2011US8058510 Method and means to modulate programmed cell death in eukaryotic cells
11/15/2011US8058509 Methods and compositions for in planta production of inverted repeats
11/15/2011US8058508 Optimizing glycan processing in plants
11/15/2011US8058507 HOPM1 mediated disease resistance to Pseudomonas syringae in Arabidopsis
11/15/2011US8058506 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants
11/15/2011US8058505 Cybrid plant of the genus Lactuca and method for producing the same
11/15/2011US8058504 Cloning of cytochrome P450 genes from Nicotiana
11/15/2011US8058422 Tissue specific promoters
11/15/2011US8058421 Promoters for regulation of gene expression in plant roots
11/15/2011US8058420 Promoters for regulation of gene expression in plant roots
11/15/2011US8058419 Promoters for regulation of gene expression in plant roots
11/15/2011US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011US8058417 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter TM1040
11/15/2011US8058408 Transcription factor having zinc finger domains
11/15/2011US8058399 Multispecific reagent for selectively stimulating cell surface receptors
11/15/2011US8058398 Modified G-CSF polypeptide
11/15/2011US8058395 Chimeric protein comprising a green fluorescent ptotein fused to a transcription factor
11/15/2011US8058257 Compositions and methods for inhibiting expression of a gene from the JC virus
11/15/2011US8058255 Methods and compositions concerning siRNA's as mediators of RNA interference
11/15/2011US8058253 Growth hormone releasing hormone treatment to decrease cholesterol levels
11/15/2011US8058252 Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors
11/15/2011US8058251 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA
11/15/2011US8058250 Administering synthetic miRNA or inhibitor as an anticarcinogenic agent that protects noncancerous cells and is effective against chemo- and radiation resistant cancer cells; breast, colon, thyroid and lung cancers; antimetastasis agents
11/15/2011US8058249 Immunostimulatory nucleic acid molecules
11/15/2011US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011US8058241 Signal transduction protein TAB2
11/15/2011US8058232 HMGB1 high affinity binding domain Box-A mutants
11/15/2011US8058231 Transcriptional regulation of high affinity IgE receptor γ-chain
11/15/2011US8058069 Lipid formulations for nucleic acid delivery
11/15/2011US8058068 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
11/15/2011US8058065 Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells
11/15/2011US8058061 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/15/2011US8058056 Method and apparatus for integrated cell handling and measurements
11/15/2011US8058053 Modification of protein glycosylation in methylotrophic yeast
11/15/2011US8058052 Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidse M
11/15/2011US8058050 Cellular permissivity factor for viruses and uses thereof
11/15/2011US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011US8058042 Method and circuit arrangement for treating biomaterial
11/15/2011US8058040 Fermentation of pentose sugars
11/15/2011US8058038 Aldolase and production process of substituted α-keto acids
11/15/2011US8058036 Microorganism of Corynebacterium genus having enhanced L-lysine productivity and a method of producing L-lysine using the same
11/15/2011US8058033 Glucoamylase variants with altered properties
11/15/2011US8058029 Method for cloning and expression of StuI restriction endonuclease and StuI methylase in E. coli
11/15/2011US8058028 Polynucleotide
11/15/2011US8058012 Five-helix protein
11/15/2011US8058004 Microarray synthesis and assembly of gene-length polynucleotides
11/15/2011US8058002 Using solid support to amplify preferential nucleotide sequences; screening for genetic polymorphisms and aberrations
11/15/2011US8058001 Oligonucleotide mediated nucleic acid recombination
11/15/2011US8057999 Extracellular serine protease
11/15/2011US8057998 Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin
11/15/2011US8057997 Nucleic acid binding compounds containing pyrazolo[3,4-D]pyrimidine analogues of purin-2,6-diamine and their uses
11/15/2011US8057993 Methods for identification of coronaviruses
11/15/2011US8057806 Viruses comprising mutant ion channel protein
11/15/2011US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011US8057801 Tick galectin
11/15/2011US8057793 Anti-CD20 antibodies and fusion proteins thereof and methods of use
11/15/2011US8057791 Human antibodies specific to KDR and uses thereof
11/15/2011US8057787 Protease resistant modified interferon-beta polypeptides
11/15/2011US8057758 Variable valve apparatus and methods
11/15/2011US8057162 vaccination directed against the hepatitis C virus (HCV);
11/15/2011CA2645812C Alteration of embryo/endosperm size during seed development
11/15/2011CA2614062C Novel genes involved in petroselinic acid biosynthesis and method for producing petroselinic acid
11/15/2011CA2539299C Method of introducing gene into plant material
11/15/2011CA2518569C Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
11/15/2011CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011CA2508468C Nucleosides or nucleotides having novel unnatural bases and use thereof
11/15/2011CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011CA2468754C Annealing control primer and its uses
11/15/2011CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011CA2417871C Enhanced 2-keto-l-gulonic acid production
11/15/2011CA2405715C Methods for selective targeting
11/15/2011CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011CA2395897C Insecticidal proteins from bacillus thuringiensis
11/15/2011CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011CA2392802C Nucleic acid isolation method and kit
11/15/2011CA2385652C Method and nucleic acids for the detection of microorganisms relevant to brewing
11/15/2011CA2384510C Method of sequencing a nucleic acid